TGen and Mayo broaden collaboration
Summary:
TGen and Mayo Clinic in Scottsdale have signed an agreement broadening the areas of research in which they will collaborate. The agreement also includes the possibility of joint staff recruitment, and shared facilities and resources.
Full Story:
TGen and Mayo Clinic in Scottsdale have signed an agreement broadening the areas of research in which they will collaborate. The agreement, which broadens the scope of a strategic plan drafted last June, also includes the possibility of joint staff recruitment, and shared facilities and resources.
The agreement extends the scope of a strategic plan drafted last June for collaborative melanoma research among the Translational Genomics Research Institute (TGen), Mayo Clinic in Scottsdale, Arizona State University, and the University of Arizona. That agreement also involved Mayo's cancer centers in Rochester, Minn., and Jacksonville, Fla.
The new agreement includes multiple areas of interest, including pancreatic cancer, hematologic malignancies, multiple myeloma, ovarian and breast cancer, and neurologic diseases such as Alzheimer's disease that have a possible genetic basis.
The two institutions have already jointly submitted four federal grant applications.
"Partnerships between organizations such as TGen and Mayo Clinic are absolutely critical in today's modern biomedical research environment," said Bert Getz, chair of the Mayo Foundation Board of Trustees and TGen board member. "Together we can have a profound impact on the care of patients with diseases and, hopefully, we will eventually even be able to prevent the development of these problems."
For more information:
"Mayo Clinic and TGen Sign New Agreement to Broaden the Scope of Research Collaboration," TGen press release, 09/25/2003